Urovalve Bladder Management System Shows Early Promise in Clinical Trial
Urovalve announced promising early results this week in a multi-site clinical trial of its Surinate Bladder Management System.
Executive Summary
[Video Profile] Interview with Bob Mills, President of Envisioneering Medical
Prostate cancer is the second leading cause of cancer death in men. The cancer stems from a malignant tumor that originates in the prostate gland. […]
[Quick Take] Interview with Robert Behl, President and CEO of PercSys
Positioned for growth as procedure shift from the hospital to the office and clinic, Percutaneous Systems, Inc. (PercSys) develops devices that make urologic and endoscopic […]
[Video Profile] Interview with Ralph Makar, President & CEO of Bioject Medical
Bioject Medical develops and markets needle-free injection technology used to administer injectable medications. Bioject’s technology works by forcing liquid medication at high speed through a […]
[Video Profile] Interview with Dr. Randal Chase, CEO of ImmunoVaccine Technologies
ImmunoVaccine Technologies (IVT) is a private biotechnology company developing therapeutic cancer and infectious disease vaccines. VacciMax technology is based on a novel approach to the […]
[Video Profile] Interview with Leah Sparks, VP Business Development of DNA Direct
Medical professional societies have mandated that genetic tests be ordered by a physician and interpreted by a genetic counselor, geneticist, or other specialist. In some […]
[Video Profile] Interview with Craig Davenport, President & CEO of Endocare
Each year over 234,000 new cases of prostate cancer are diagnosed in the U.S. Treatment options include surgery, radiation therapy, hormone therapy, “watchful waiting” and […]
[Video Profile] Interview with Ron Andrews, President & CEO of Clarient
Clarient provides access to technologies and services for the characterization, assessment and treatment of cancer. The company offers a full range of diagnostic technologies and […]
[Video Profile] Interview with Jon Garfield, CEO of Clearant
Orthopedic tissue market is large and growing Technological advancements in the repair and replacement of damaged bone and soft tissue has driven the growth of […]
[Video Profile] Interview with Mitchell Seyedin, President & CEO of ISTO Technologies
Within the sports medicine market, repair of cartilage injuries represents one of the greatest unmet medical needs. In the U.S., approximately 500,000 cartilage lesions are […]